Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 1 | BMC Medicine

Fig. 1

From: Did the resurgence of childhood lower respiratory infections offset the initial benefit of COVID-19-related non-pharmaceutical interventions in children? A time-series analysis

Fig. 1

Overall impact of non-pharmaceutical interventions on the monthly incidence of lower respiratory tract infections of children < 18 years requiring hospitalisation from January 2015 to March 2023 in France (N = 671,323). Incidence is expressed as the number of hospitalisations per 100,000 children per month. The black line shows the observed data. The blue line shows the model estimates based on observed data using the quasi-Poisson regression. The dashed red line shows the expected values assuming the NPI were not implemented using the same quasi-Poisson model. The blue and red shading indicates the 95% confidence intervals. Vertical dashed lines indicate NPI implementation and lifting. Pre-NPI period: 1 January 2015 to 31 March 2020. NPI period: 1 April 2020 to 31 March 2021. NPI-lifting period: 1 April 2021 to 31 March 2023. Abbreviations: NPI, non-pharmaceutical intervention; LRTI, lower respiratory tract infection

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us